Lan Gao

发表

Psychometric Evaluation of the Mandarin HeartQoL Health-Related Quality of Life Questionnaire Among Patients With Ischemic Heart Disease in China.

Luan Luan, Hao Hu, N. Oldridge, 2022, Value in health regional issues.

Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: A meta-analysis of randomized placebo-controlled trials

F. Zhao, Lan Gao, Shu-chuen Li, 2013, Epilepsy Research.

Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples

Hao Hu, F. Zhao, Lan Gao, 2016, PloS one.

Adding a new anticoagulant or antiplatelet agent for patient receiving aspirin after an acute coronary syndrome? - Results from a pairwise and network meta-analysis of randomized-controlled trials

Lan Gao, Shu-chuen Li, 2015 .

Health-Related Quality of Life and Willingness to Pay per Quality-Adjusted Life-Year Threshold-A Study in Patients with Epilepsy in China.

Lan Gao, Shu-chuen Li, Li Xia, 2015, Value in health regional issues.

Validation of the Chinese version of the NUCOG cognitive screening tool in patients with epilepsy, dementia and other neurological disorders

M. Walterfang, D. Velakoulis, Lan Gao, 2014, Journal of Clinical Neuroscience.

Psychometric properties of Chinese language Liverpool Seizure Severity Scale 2.0 (LSSS 2.0) and status and determinants of seizure severity for patients with epilepsy in China

Lan Gao, Shu-chuen Li, Li Xia, 2014, Epilepsy & Behavior.

Efficacy and Safety of Thrombin-Receptor Antagonist (Atopaxar and Vorapaxar) in Patients with Acute Coronary Syndrome or Coronary Artery Disease-A Meta-Analysis of Randomized Controlled Trials.

F. Zhao, Lan Gao, Shu-chuen Li, 2015, Value in health regional issues.

Ef fi cacy and Safety of Thrombin-Receptor Antagonist ( Atopaxar and Vorapaxar ) in Patients with Acute Coronary Syndrome or Coronary Artery Disease — A Meta-Analysis of Randomized Controlled Trials

F. Zhao, Lan Gao, Shu-chuen Li, 2015 .

COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN TYPE 2 DIABETES PATIENTS IN CHINA

F. Zhao, Lan Gao, Shu-chuen Li, 2012, International Journal of Technology Assessment in Health Care.

Burden of Disease Studies in the Asia-Pacific Region: Are There Enough being Performed to Provide Information for Evidence-Based Health Policy?

F. Zhao, Lan Gao, Shu-chuen Li, 2013, Value in health regional issues.

Reliability and validity of QOLIE-10 in measuring health-related quality of life (HRQoL) in Chinese epilepsy patients

Lan Gao, Shu-chuen Li, Li Xia, 2014, Epilepsy Research.

Validation of a Chinese version of the Quality of Well‐Being Scale–Self‐Administered (QWB‐SA) in patients with epilepsy

Lan Gao, Shu-chuen Li, Li Xia, 2013, Epilepsia.

Burden of epilepsy: A prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy

Lan Gao, Shu-chuen Li, Li Xia, 2015, Epilepsy Research.

PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials

Lan Gao, Shu-chuen Li, 2012 .

Reliability and validity of QOLIE-10 in measuring health-related quality of life (HRQoL) in Chinese epilepsy patients

Lan Gao, Shu-chuen Li, Li Xia, 2014, Epilepsy Research.

Burden of epilepsy: A prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy

Lan Gao, Shu-chuen Li, Li Xia, 2015, Epilepsy Research.